- Introducing Hyaluronic Acid, Exosomes, and PDRN
SEOUL,
South Korea, Dec. 30,
2024 /PRNewswire/ -- Maypharm Co., Ltd., a leading
innovator in medical and dermo-cosmetic products, proudly
introduces the global launch of Hyalmass Aqua-Exosome, a
groundbreaking hybrid mesotherapy filler designed to redefine skin
hydration and revitalization.
Maypharm Co., Ltd. is set to revolutionize the aesthetic
industry with the introduction of Hyalmass Aqua-Exosome. This
cutting-edge hybrid filler combines the power of hyaluronic acid,
exosomes, and PDRN to maximize skin hydration, elasticity, and
regeneration.
Hyalmass Aqua-Exosome is a breakthrough in aesthetic innovation,
offering unmatched benefits for skin health and rejuvenation.
Unlike traditional hydration fillers that focus solely on moisture,
Hyalmass Aqua-Exosome elevates skin health standards by leveraging
the regenerative potential of exosomes and PDRN.
"At Maypharm, we are committed to pushing the boundaries of
aesthetic technology to deliver transformative results for our
customers," says KWON JONGWOOK, CEO of Maypharm Co., Ltd. "With
Hyalmass Aqua-Exosome, we aim to provide a comprehensive solution
that not only hydrates the skin but also promotes long-term
elasticity and regeneration."
Key Features of Hyalmass Aqua-Exosome:
- Advanced Formulation: Hyalmass Aqua-Exosome contains a
unique blend of hyaluronic acid, exosomes derived from human stem
cell conditioned media and plant sources, and PDRN
(polydeoxyribonucleotide). This innovative combination maximizes
skin regeneration and elasticity, resulting in visibly smoother and
more radiant skin.
- Prefilled Syringes: Hyalmass Aqua-Exosome comes
conveniently packaged in prefilled syringes, ensuring optimal
hygiene and safety for both patients and practitioners.
- Long-lasting Efficacy: Utilizing high-purity,
high-molecular-weight raw materials, Hyalmass Aqua-Exosome delivers
long-lasting benefits to the skin, enhancing its viscoelasticity
and overall vitality.
- Stimulates Fibroblasts: The primary ingredient in
Hyalmass Aqua-Exosome stimulates fibroblasts to promote collagen
and elastin production, leading to improved skin elasticity,
anti-aging effects, and enhanced skin regeneration.
In comparison to traditional hydration fillers, Hyalmass
Aqua-Exosome emerges as the superior choice. While conventional
hydration fillers deliver quick moisture, their benefits are often
limited to hydration alone, offering minimal regenerative effects.
In contrast, Hyalmass Aqua-Exosome not only provides immediate
hydration with hyaluronic acid but also promotes long-term skin
elasticity and regeneration through the inclusion of exosomes and
PDRN. This innovative formulation leads to a significant overall
improvement in skin condition, positioning Hyalmass Aqua-Exosome as
a revolutionary advancement in aesthetics.
With the launch of Hyalmass Aqua-Exosome, Maypharm Co., Ltd.
continues its commitment to innovation, excellence, and customer
satisfaction in the field of cosmetic medicine and dermo-cosmetic
products. Experience the future of medical and aesthetics with
Hyalmass Aqua-Exosome and unlock the secret to radiant,
youthful-looking skin.
Partnership with Beauty Factory:
The production of Hyalmass Aqua-Exosome is supported by Beauty
Factory, a leading Korean medical aesthetics manufacturer renowned
for its commitment to innovation and quality. While Maypharm is
responsible for the global distribution and commercialization of
Hyalmass Aqua-Exosome, Beauty Factory's advanced manufacturing
capabilities ensure that this product meets the highest industry
standards.
Beauty Factory operates state-of-the-art facilities that comply
with international Good Manufacturing Practice (GMP) guidelines.
With their proprietary HALO manufacturing technology, developed
through partnerships with prestigious academic institutions like
KINS Lab at Seoul National University
and the Biomaterial Synthesis Lab at Sookmyung University, Beauty
Factory maintains its leadership in medical aesthetics. Their
collaborations with renowned global R&D partners in
Poland and Germany further enhance the scientific and
technological advancements that support the creation of Hyalmass
Aqua-Exosome.
Quality Control at Beauty Factory:
Beauty Factory's rigorous quality control process ensures that
every product, including Hyalmass Aqua-Exosome, meets the highest
standards for safety and efficacy. With a 7-step quality control
(QC) system in place, Beauty Factory guarantees that all products
undergo meticulous testing to ensure consistent and reliable
performance across all applications.
Maypharm, in collaboration with Beauty Factory, is excited to
introduce a product that combines cutting-edge technology and
advanced formulation to not only provide immediate skin hydration
but also support long-term skin health and rejuvenation,
establishing a new standard in the aesthetic industry.
For more information about Hyalmass Aqua-Exosome and other
products from Maypharm Co., Ltd., please visit
www.maypharm.net or contact sales@maypharm.co.kr.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/maypharm-unveils-revolutionary-hybrid-filler-hyalmass-aqua-exosome-the-future-of-skin-hydration-and-regeneration-302339515.html
SOURCE Maypharm
